258 related articles for article (PubMed ID: 25598534)
1. Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.
Rees JR; Zens MS; Celaya MO; Riddle BL; Karagas MR; Peacock JL
Int J Cancer; 2015 Aug; 137(4):878-884. PubMed ID: 25598534
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic status and non-melanoma skin cancer: a nationwide cohort study of incidence and survival in Denmark.
Steding-Jessen M; Birch-Johansen F; Jensen A; Schüz J; Kjær SK; Dalton SO
Cancer Epidemiol; 2010 Dec; 34(6):689-95. PubMed ID: 20638927
[TBL] [Abstract][Full Text] [Related]
3. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
4. Personal history of keratinocyte carcinoma is associated with reduced risk of death from invasive melanoma in men.
Song F; Chen ST; Li X; Han J
J Am Acad Dermatol; 2018 May; 78(5):957-963. PubMed ID: 29317282
[TBL] [Abstract][Full Text] [Related]
5. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
6. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
8. All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis.
Wehner MR; Cidre Serrano W; Nosrati A; Schoen PM; Chren MM; Boscardin J; Linos E
J Am Acad Dermatol; 2018 Apr; 78(4):663-672.e3. PubMed ID: 29146125
[TBL] [Abstract][Full Text] [Related]
9. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
10. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
[TBL] [Abstract][Full Text] [Related]
11. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
12. Forearm hair density and risk of keratinocyte cancers in Australian adults.
von Schuckmann LA; Hughes MC; Green AC; van der Pols JC
Arch Dermatol Res; 2016 Nov; 308(9):617-624. PubMed ID: 27590883
[TBL] [Abstract][Full Text] [Related]
13. Non-melanoma skin cancer and ten-year all-cause mortality: a population-based cohort study.
Jensen AØ; Lamberg AL; Jacobsen JB; Braae Olesen A; Sørensen HT
Acta Derm Venereol; 2010 Jul; 90(4):362-7. PubMed ID: 20574600
[TBL] [Abstract][Full Text] [Related]
14. Occupation and keratinocyte cancer risk: a population-based case-control study.
Marehbian J; Colt JS; Baris D; Stewart P; Stukel TA; Spencer SK; Karagas MR
Cancer Causes Control; 2007 Oct; 18(8):895-908. PubMed ID: 17638107
[TBL] [Abstract][Full Text] [Related]
15. Non melanoma skin cancer and subsequent cancer risk.
Rees JR; Zens MS; Gui J; Celaya MO; Riddle BL; Karagas MR
PLoS One; 2014; 9(6):e99674. PubMed ID: 24937304
[TBL] [Abstract][Full Text] [Related]
16. Do incident and new subsequent cases of non-melanoma skin cancer registered in a Danish prospective cohort study have different 10-year mortality?
Jensen AØ; Olesen AB; Dethlefsen C; Sørensen HT
Cancer Detect Prev; 2007; 31(5):352-8. PubMed ID: 18031945
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study.
Sharp K; Olafsdottir EJ; Sahni DR; Madsen S; Grant-Kels JM; Kristjansson A; Hoyt DW; Ungar JP; Frigerio A; Jonasson JG; Adalsteinsson JA
J Am Acad Dermatol; 2024 Jan; 90(1):91-97. PubMed ID: 37758026
[TBL] [Abstract][Full Text] [Related]
18. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
[TBL] [Abstract][Full Text] [Related]
19. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
Wu S; Cho E; Li WQ; Qureshi AA
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
[TBL] [Abstract][Full Text] [Related]
20. Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial.
Baibergenova AT; Weinstock MA;
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1109-15. PubMed ID: 21923839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
